Simplex Trading
HRTX icon

Simplex Trading’s Heron Therapeutics HRTX Stock Holding History

Simplex Trading’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$720 Buy
+900
New +$1.04K ﹤0.01% 8673
2025
Q4 		– Sell
-1,000
Closed -$1K – 9194
2025
Q3 		$1K Sell
1,000
-9,600
-91% -$15.2K ﹤0.01% 8816
2025
Q2 		$21K Sell
10,600
-9,200
-46% -$18.8K ﹤0.01% 6723
2025
Q1 		$43K Buy
19,800
+10,100
+104% +$19.6K ﹤0.01% 5918
2024
Q4 		$14K Sell
9,700
-300
-3% -$486 ﹤0.01% 6949
2024
Q3 		$19K Sell
10,000
-12,700
-56% -$30.3K ﹤0.01% 6709
2024
Q2 		$79K Sell
22,700
-13,600
-37% -$41.8K ﹤0.01% 5614
2024
Q1 		$100K Buy
36,300
+24,200
+200% +$60.8K ﹤0.01% 5574
2023
Q4 		$20K Buy
+12,100
New +$13.3K ﹤0.01% 6931
2023
Q3 		– Sell
-1,000
Closed -$1K – 9126
2023
Q2 		$1K Sell
1,000
-4,800
-83% -$8.56K ﹤0.01% 8631
2023
Q1 		$8K Buy
+5,800
New +$14.5K ﹤0.01% 7723
2022
Q4 		– Sell
-58,100
Closed -$245K – 9688
2022
Q3 		$245K Buy
58,100
+42,100
+263% +$165K ﹤0.01% 4349
2022
Q2 		$44K Sell
16,000
-58,000
-78% -$233K ﹤0.01% 6669
2022
Q1 		$423K Buy
74,000
+29,500
+66% +$216K ﹤0.01% 4054
2021
Q4 		$406K Buy
44,500
+38,100
+595% +$389K ﹤0.01% 4107
2021
Q3 		$96K Buy
6,400
+200
+3% +$2.44K ﹤0.01% 6671
2021
Q2 		$96K Buy
6,200
+5,960
+2,483% +$94.8K ﹤0.01% 6784
2021
Q1 		$389K Buy
+240
New +$4.28K ﹤0.01% 3743
2020
Q4 		– Sell
-110
Closed -$163K – 8638
2020
Q3 		$163K Sell
110
-201
-65% -$3.14K ﹤0.01% 4347
2020
Q2 		$457K Sell
311
-638
-67% -$10.5K ﹤0.01% 3008
2020
Q1 		$1.11M Buy
949
+639
+206% +$12K ﹤0.01% 1778
2019
Q4 		$728K Buy
310
+198
+177% +$4.38K ﹤0.01% 2375
2019
Q3 		$207K Sell
112
-46
-29% -$847 ﹤0.01% 3530
2019
Q2 		$293K Buy
158
+23
+17% +$459 ﹤0.01% 3095
2019
Q1 		$329K Buy
135
+68
+101% +$1.78K ﹤0.01% 3099
2018
Q4 		$173K Sell
67
-33
-33% -$907 ﹤0.01% 3301
2018
Q3 		$316K Sell
100
-680
-87% -$25.3K ﹤0.01% 3114
2018
Q2 		$3.03M Buy
780
+643
+469% +$20.5K 0.01% 845
2018
Q1 		$4K Buy
137
+82
+149% +$1.86K ﹤0.01% 4788
2017
Q4 		$2K Sell
55
-33
-38% -$538 ﹤0.01% 5187
2017
Q3 		$12K Buy
88
+82
+1,367% +$1.29K ﹤0.01% 3601
2017
Q2 		$1K Sell
6
-53
-90% -$768 ﹤0.01% 5616
2017
Q1 		$3K Buy
59
+15
+34% +$208 ﹤0.01% 4996
2016
Q4 		$11K Sell
44
-341
-89% -$5.35K ﹤0.01% 3647
2016
Q3 		$17K Buy
385
+238
+162% +$4.42K ﹤0.01% 3125
2016
Q2 		$20K Sell
147
-49
-25% -$957 ﹤0.01% 2896
2016
Q1 		$27K Buy
196
+191
+3,820% +$3.77K ﹤0.01% 2511
2015
Q4 		$9K Sell
5
-581
-99% -$15.5K ﹤0.01% 3392
2015
Q3 		$495K Buy
586
+230
+65% +$7.67K 0.04% 451
2015
Q2 		$39K Buy
356
+280
+368% +$5.27K ﹤0.01% 1885
2015
Q1 		$1K Buy
+76
New +$857 ﹤0.01% 4492

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Simplex Trading's HRTX Position: Q1 2026 in Review

Simplex Trading reduced its Heron Therapeutics (HRTX) stake by 89% in Q1 2026, selling an estimated $118K and leaving 12,774 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #7340.

Simplex Trading first reported a position in HRTX in Q1 2015 and has held it in 35 quarters since. The position peaked at $1.47M in Q2 2018. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Simplex Trading held 12,774 shares of Heron Therapeutics worth $10.2K as of Q1 2026.
  • Simplex Trading sold 101,830 Heron Therapeutics shares in Q1 2026, an estimated $118K.
  • Heron Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7340 holding.
  • Simplex Trading first reported a position in Heron Therapeutics in Q1 2015 and has held it in 35 quarters since.
  • Simplex Trading's Heron Therapeutics position peaked at $1.47M in Q2 2018.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.